Prognostic value of XIAP and survivin expression in locally advanced breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy

Prognostic value of XIAP and survivin expression in locally advanced breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy

Introduction Neoadjuvant treatment in locally advanced breast cancer (LABC) is intended to decrease the cancer mass, increase the likelihood of radical resection and improve survival. Resistance to chemotherapy may depend on cellular expression of anti-apoptotic proteins. XIAP and survivin are the m...

Full description

Bibliographic Details
Main Authors: Piotr Pluta, Dorota Jesionek-Kupnicka, Agnieszka Pluta, Kamil Brzozowski, Marcin Braun, Joanna Kubicka-Wołkowska, Janusz Piekarski
Format: Article
Language:English
Published: Termedia Publishing House 2019-10-01
Series:Archives of Medical Science
Subjects:
apoptosis
prognosis
breast neoplasm
Online Access:https://www.archivesofmedicalscience.com/Prognostic-value-of-XIAP-and-survivin-expression-in-locally-advanced-breast-cancer,111843,0,2.html

Internet

https://www.archivesofmedicalscience.com/Prognostic-value-of-XIAP-and-survivin-expression-in-locally-advanced-breast-cancer,111843,0,2.html

Similar Items